Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
October 5, 2025Indian Journal of Pharmacy PracticeOpen Access

Comparing the Cost-Effectiveness of Antibiotics for LRTI’s: A Hospital-Based Study in Pakistan

View Full Paper
Ask AI
Bookmark
Share

Authors

AHAli HassanMAMuhammad AmirNRNaeem Ur Rehman

Discussion

Loading...

Member takes

Overview

Prospective observational study evaluates antibiotic cost-effectiveness for LRTIs, highlighting optimal choices.

Key Points

  • Co-amoxiclav emerged as the most cost-effective antibiotic for treating LRTIs, demonstrating the lowest cost effectiveness ratio at 13.998.
  • Among five antibiotics analyzed, amikacin and ceftriaxone were next in line for cost-effectiveness, while piperacillin/tazobactam and moxifloxacin showed higher cost effectiveness ratios.
  • The study included 123 LRTI patients, using a strategy based on percentage healing and symptom-free days to assess effectiveness of treatments.
  • Findings underline the significance of cost-effectiveness analysis in antibiotic selection to improve patient outcomes and optimize healthcare resources.

Cite This Study

Hassan et al. (2025) studied this question.

synapsesocial.com/papers/68e2537cd6d66a53c24743c0https://doi.org/10.5530/ijopp.20260373
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1PHARMACOECONOMICS EVALUATION OF ANTIBIOTIC THERAPY IN HOSPITILIZED PATIENTS2026
  2. 2ANALYSIS OF COST EFFECTIVENESS OF ANTIBIOTIC USE IN TYPHOD FEVER PATIENTS AT KARTINI RANGKASBITUNG HOSPITAL IN 20222024
  3. 3Cost effectiveness analysis of ceftriaxone with cefoperazon in thypoid patients at x mataram hospital2024 · 2 citations
  4. 4Cost-Consequence Analysis of Levofloxacin Compared to Ceftriaxone in Community-Acquired Pneumonia of Adult Inpatients at X Hospital Surakarta2024
  5. 5Comprehensive pharmacoepidemiological and clinical-economic analysis of antibacterial drugs consumed during the pandemic at the hospital level in Aktobe, Kazakhstan2024